27th Annual SoCalBio 
Investor & Partnering Conference

October 1 – 2, 2025 (PDT) 
Hyatt Regency Newport Beach 

Register Now

The SoCalBio conference is a platform that highlights the cutting-edge value-based bioscience advancements originating from Southern California. It serves as a forum for exploring streamlined approaches to effectively bring these innovations to market. The conference will host a remarkable lineup of at least 30 company presentations alongside enlightening plenary sessions, business roundtables, and VC one-on-one sessions. These presentations will exemplify the robustness and promising future of the bioscience industry in the Greater Los Angeles region, encompassing Los Angeles, Orange County, and nearby communities.

Plenary Sessions

Presenting Companies

Networking

Whova plugin (Registration)

Whova plugin (Agenda)

Speakers Lorem Ipsum

Lorem ipsum dolor sit amet consectetur. Neque adipiscing a augue tempus malesuada cras. Feugiat suspendisse feugiat mattis donec iaculis. Convallis diam ut faucibus nunc.

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Lorem ipsum

Lorem ipsum egestas scelerisque

Investors

Premier opportunity to have private 1-on-1 meetings with life science investors to get feedback and potential funding opportunities.

Presenting Companies

The Conference offers a platform for entrepreneurs to pitch their companies to potential investors and partners. As a service to the SoCal bioscience community, SoCalBio Does NOT charge presenting companies.

Amplifi DX, Inc.

AmplifiDx is developing a best-in-class molecular point-of-care (POC) platform for rapid, affordable, and highly accurate infectious disease testing for Family & Women’s Health

ASiMA Health

Asima Health is developing a highly-sensitive, early detection, multi-cancer blood test to reduce the human and financial burden of cancer testing

Arc Medical

Arc Medical​ is A clinical stage company improving surgical patient recovery by preventing internal adhesions

Aufero Medical

Aufero is introducing TruContact, will be the first device on the market that actively enhancing catheter stability in cardiac ablation therapy

Avesta76 Therapeutics, Inc.

Avesta76 Therapeutics is advancing a novel cancer treatment that has demonstrated complete tumor elimination within 6 weeks in preclinical models.

CERN Corp

Develop and commercialize an effective, non-drug treatment for both fungal and bacterial vaginosis using low-level microbicidal light and an accompanying non-drug, photosensitizer/lubricant.

DimerX

NIH-backed, late-stage biopharmaceutical company leveraging a proprietary dimer technology platform to create novel, non-addictive therapeutics for acute and chronic pain, addressing high-impact, underserved medical needs.

FanousPhotonics

A cost-effective and compact digital pathology microscope to bridge the disparity between expensive, large and slow digital pathology scanners and the traditional pathology workflow that is manual, tedious, and prone to inaccuracies.

Hybrid Biotherapeutics

Pioneering a revolutionary approach to cancer immunotherapy leveraging the innate biological power of Hybrid Neutrophils.

Ilya Pharma AB

Ilya Pharma is developing the future of local-acting immunotherapies and fighting disease by local instructions to immune cells and killing of multi drug resistant pathogens

Kidod Science

IVD device that would be one point of care diagnostic: one device that will diagnose multiple diseases in early stages using one sample.

Innovotex Inc

Innovotex is redefining cancer treatment with a clinically de-risked platform that precisely targets aggressive, treatment-resistant tumors.

Northern Vascular Systems

developing a light-activated liquid embolic platform. Our three part system is an investigational technology in early development as a novel approach to embolization.

Olive Bio

OliveBio’s mission is to solve the world’s plastic pollution crisis through making bioplastics manufacturing more scalable and cost-effective.

Persperion Diagnostics

Persperion Diagnostics is pioneering sweat-based diagnostics, starting with a painless, simple, and affordable solution for glucose monitoring.

Pretika MedTech Corporation

Pretika Medical is modernizing wound care management with “Connected” technology. An enabled medical device system and digital health technology.

Sonaro AI

Sonaro AI is developing 3D diagnostic ultrasound for vascular disease made simple and accessible

Squid Glaucoma hybridShunt

A hybrid device that combines features of a glaucoma drainage device (GDD) and minimally invasive glaucoma surgery (MIGS) device.

Sylamore Bio

SylamoreBio is a biotech company focused on delivering therapeutic modalities to CNS and other hard-to-treat tissues.

Trialynx

Trialynx is reimagining clinical trial development with agentic AI. We transform disjointed, siloed, error-prone, and costly processes into a collaborative, intelligent platform

Viridian Biometals

Viridian’s mission is to protect people and the planet while reducing the cost of refining metals critical to the energy transition.

SOME OF OUR TRUSTED PARTNERS

image 239
image 236
rkl
image 238
aon
BBS-Programs-Website-Airgas1-300x141
UPS-Healthcare

Sign Up/Chat Lorem Ipsum Delores

Lorem ipsum dolor sit amet consectetur. Condimentum tristique in aenean odio risus convallis amet condimentum nam. Posuere fusce nisl eget tincidunt integer mi. Iaculis donec eget dui id.

Join Today
Contact Us